Clinical trials
Ovarian Neoplasms trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 13 |
| Terminated | 6 |
| Active, not recruiting | 5 |
| Unknown status | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Bergonié | 5 |
| Centre Francois Baclesse | 4 |
| Centre Oscar Lambret | 4 |
| Hospices Civils de Lyon | 4 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Institut Claudius Regaud | 3 |
| Institut Curie | 3 |
| Institut de Cancérologie de Lorraine | 3 |
| AGO Study Group | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 53 |
| Breast Neoplasms | 9 |
| Endometrial Neoplasms | 5 |
| Uterine Cervical Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Fallopian Tube Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Neoplasms | 4 |
| Head and Neck Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.